ID: ALA3220409

Max Phase: Preclinical

Molecular Formula: C19H18O3

Molecular Weight: 294.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)c1cccc(C2=CC(C)(C)Oc3cc(O)ccc32)c1

Standard InChI:  InChI=1S/C19H18O3/c1-12(20)13-5-4-6-14(9-13)17-11-19(2,3)22-18-10-15(21)7-8-16(17)18/h4-11,21H,1-3H3

Standard InChI Key:  VMTQKJDDLURXHF-UHFFFAOYSA-N

Associated Targets(non-human)

C3H 10T1/2 488 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 294.35Molecular Weight (Monoisotopic): 294.1256AlogP: 4.20#Rotatable Bonds: 2
Polar Surface Area: 46.53Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.03CX Basic pKa: CX LogP: 3.56CX LogD: 3.55
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.84Np Likeness Score: 0.93

References

1. Oh S, Cho SW, Yang J, Sun HJ, Chung YS, Shin CS, Park SB.  (2011)  Discovery of a novel benzopyranyl compound as a potent in vitro and in vivo osteogenic agent,  (1): [10.1039/C0MD00149J]

Source